Metraipolis › archive › dc_795196102c7c
Case Report: Ofatumumab for the treatment of refractory anti-NMDAR-positive autoimmune encephalitis — Europe PMC PMID:42358975
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42358975
- DOI
- 10.3389/fimmu.2026.1754979
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T04:40:07.952Z
- SHA-256 of the archived text
9620c22f0e97964cdd0768c4ecc6972c2f092c38f0e4c30fc9f6d2890176b266- Stable URL of this page
https://metraipolis.com/documento/dc_795196102c7c
How to cite
Case Report: Ofatumumab for the treatment of refractory anti-NMDAR-positive autoimmune encephalitis — Europe PMC PMID:42358975 — Europe PMC (en), https://europepmc.org/article/MED/42358975 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_795196102c7c (Metraipolis archive dc_795196102c7c, sha256 9620c22f0e97964cdd0768c4ecc6972c2f092c38f0e4c30fc9f6d2890176b266)
BibTeX
@misc{dc795196102c7c,
title = {Case Report: Ofatumumab for the treatment of refractory anti-NMDAR-positive autoimmune encephalitis — Europe PMC PMID:42358975},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42358975},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_795196102c7c; sha256 9620c22f0e97964cdd0768c4ecc6972c2f092c38f0e4c30fc9f6d2890176b266},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42358975. Agents can read the archived copy with the MCP tool read_document.